Key Points

In 2023, surveillance of Campylobacter infections in France confirmed the epidemiological and biological trends already observed in recent years:

• a predominance of the C. jejuni species;

• a higher reported incidence among children under 10 and among men;

• a resurgence of infection cases during the summer months;

• high resistance rates to fluoroquinolones and tetracyclines, which have remained stable in recent years;

• low rates of combined resistance to fluoroquinolones and tetracycline;

• no significant increase in resistance rates to antibiotics routinely tested.